147 related articles for article (PubMed ID: 15371450)
21. Intact kinase homology domain of natriuretic peptide receptor-B is essential for skeletal development.
Hachiya R; Ohashi Y; Kamei Y; Suganami T; Mochizuki H; Mitsui N; Saitoh M; Sakuragi M; Nishimura G; Ohashi H; Hasegawa T; Ogawa Y
J Clin Endocrinol Metab; 2007 Oct; 92(10):4009-14. PubMed ID: 17652215
[TBL] [Abstract][Full Text] [Related]
22. Modulation by brain natriuretic peptide of GABA receptors on rat retinal ON-type bipolar cells.
Yu YC; Cao LH; Yang XL
J Neurosci; 2006 Jan; 26(2):696-707. PubMed ID: 16407567
[TBL] [Abstract][Full Text] [Related]
23. Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells.
Crook RB; Chang AT
Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):49-55. PubMed ID: 9164840
[TBL] [Abstract][Full Text] [Related]
24. Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B.
Hagiwara H; Sakaguchi H; Itakura M; Yoshimoto T; Furuya M; Tanaka S; Hirose S
J Biol Chem; 1994 Apr; 269(14):10729-33. PubMed ID: 7908295
[TBL] [Abstract][Full Text] [Related]
25. Agonistic induction of a covalent dimer in a mutant of natriuretic peptide receptor-A documents a juxtamembrane interaction that accompanies receptor activation.
Labrecque J; Deschênes J; McNicoll N; De Léan A
J Biol Chem; 2001 Mar; 276(11):8064-72. PubMed ID: 11124937
[TBL] [Abstract][Full Text] [Related]
26. Renal hyporesponsiveness to atrial natriuretic peptide in congestive heart failure results from reduced atrial natriuretic peptide receptor concentrations.
Bryan PM; Xu X; Dickey DM; Chen Y; Potter LR
Am J Physiol Renal Physiol; 2007 May; 292(5):F1636-44. PubMed ID: 17264312
[TBL] [Abstract][Full Text] [Related]
27. ATP-independent activation of natriuretic peptide receptors.
Antos LK; Abbey-Hosch SE; Flora DR; Potter LR
J Biol Chem; 2005 Jul; 280(29):26928-32. PubMed ID: 15911610
[TBL] [Abstract][Full Text] [Related]
28. Atrial natriuretic factor and C-type natriuretic peptide induce retraction of human thyrocytes in monolayer culture via guanylyl cyclase receptors.
Sellitti DF; Lagranha C; Perrella G; Curcio F; Doi SQ
J Endocrinol; 2002 Apr; 173(1):169-76. PubMed ID: 11927396
[TBL] [Abstract][Full Text] [Related]
29. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
[TBL] [Abstract][Full Text] [Related]
30. Depletion of natriuretic peptide C receptors eliminates inhibitory effects of C-type natriuretic peptide on evoked neurotransmitter efflux.
Trachte GJ
J Pharmacol Exp Ther; 2000 Jul; 294(1):210-5. PubMed ID: 10871314
[TBL] [Abstract][Full Text] [Related]
31. Homologous and lysophosphatidic acid-induced desensitization of the atrial natriuretic peptide receptor, guanylyl cyclase-A, in MA-10 leydig cells.
Müller D; Cortes-Dericks L; Budnik LT; Brunswig-Spickenheier B; Pancratius M; Speth RC; Mukhopadhyay AK; Middendorff R
Endocrinology; 2006 Jun; 147(6):2974-85. PubMed ID: 16527839
[TBL] [Abstract][Full Text] [Related]
32. C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells.
Rahmutula D; Gardner DG
Endocrinology; 2005 Nov; 146(11):4968-74. PubMed ID: 16109786
[TBL] [Abstract][Full Text] [Related]
33. Conservation of the kinaselike regulatory domain is essential for activation of the natriuretic peptide receptor guanylyl cyclases.
Koller KJ; de Sauvage FJ; Lowe DG; Goeddel DV
Mol Cell Biol; 1992 Jun; 12(6):2581-90. PubMed ID: 1350322
[TBL] [Abstract][Full Text] [Related]
34. Prolonged atrial natriuretic peptide exposure stimulates guanylyl cyclase-a degradation.
Flora DR; Potter LR
Endocrinology; 2010 Jun; 151(6):2769-76. PubMed ID: 20382697
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells.
Hutchinson HG; Trindade PT; Cunanan DB; Wu CF; Pratt RE
Cardiovasc Res; 1997 Jul; 35(1):158-67. PubMed ID: 9302360
[TBL] [Abstract][Full Text] [Related]
36. Forced homodimerization by site-directed mutagenesis alters guanylyl cyclase activity of natriuretic peptide receptor B.
Langenickel T; Buttgereit J; Pagel I; Dietz R; Willenbrock R; Bader M
Hypertension; 2004 Feb; 43(2):460-5. PubMed ID: 14691198
[TBL] [Abstract][Full Text] [Related]
37. Adenine nucleotides decrease the apparent Km of endogenous natriuretic peptide receptors for GTP.
Antos LK; Potter LR
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1756-63. PubMed ID: 17848634
[TBL] [Abstract][Full Text] [Related]
38. The indolocarbazole, Gö6976, inhibits guanylyl cyclase-A and -B.
Robinson JW; Lou X; Potter LR
Br J Pharmacol; 2011 Sep; 164(2b):499-506. PubMed ID: 21366551
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation of the kinase homology domain is essential for activation of the A-type natriuretic peptide receptor.
Potter LR; Hunter T
Mol Cell Biol; 1998 Apr; 18(4):2164-72. PubMed ID: 9528788
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, Not NPR-A, is the predominant natriuretic peptide receptor in the failing heart.
Dickey DM; Flora DR; Bryan PM; Xu X; Chen Y; Potter LR
Endocrinology; 2007 Jul; 148(7):3518-22. PubMed ID: 17412809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
